Skip to content
MedsAcross

Medicine

Felbamate 600 mg/5 mL oral suspension

Felbamate · Oral
Available on requestPrescription onlyUS FDAGeneric name

Felbamate 600 mg/5 mL oral suspension is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Felbamate
Brand
Sold under the generic name
Strength
600 mg/5 mL
Dosage form
Oral suspension
Route
Oral
Packs
237 mL, 473 mL and 5 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaAmneal PharmaceuticalsNorthStar RxNovitium Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AX10 Felbamate
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
16 December 2011
Identifiers
RxCUI 310285DailyMed set ID 556de35d-3b98-48d3-a670-50e9d93437a4, 2e325d79-d0a4-4af7-b09b-96ee5a5b2a37, 81c8a2e1-732c-4467-84e9-53fef1655ee2 +1NDC 16714-775, 65162-686, 70954-051 +1Application ANDA206314, ANDA202385, ANDA211333

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
237 mL in 1 bottle51672-4172-1Sun Pharmaceutical IndustriesIndia16 June 2017
473 mL in 1 bottle51672-4172-9Sun Pharmaceutical IndustriesIndia16 June 2017
237 mL in 1 bottle65162-686-88Amneal Pharmaceuticals16 December 2011
473 mL in 1 bottle65162-686-90Amneal Pharmaceuticals16 December 2011
237 mL in 1 bottle70954-051-10Novitium Pharma15 July 2022
473 mL in 1 bottle70954-051-20Novitium Pharma15 July 2022
237 mL in 1 bottle16714-775-01Northstar RX10 April 2018
473 mL in 1 bottle16714-775-02Northstar RX10 April 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 29 July 1993Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Felbamate

Clinical summary

Felbamate is an anti-epileptic agent indicated as a first line antiepileptic treatment. It is available as tablets and oral suspension. MedsAcross supplies Felbamate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Felbamate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Felbamate 600 mg/5 mL oral suspension for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.